{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:11:44Z","timestamp":1791173504988,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.gendis.2025.101990","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:57:47Z","timestamp":1766131067000},"page":"101990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic resistance in cancer: lncRNAs as modulators and targets for cancer therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Ashiq","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urooj","family":"Azmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Khatoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Murtaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaynaat","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urooj","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinza","family":"Ishaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gendis.2025.101990_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1453268","article-title":"Editorial: non-coding RNAs as emerging players in the development, diagnosis, and treatment of cancer","volume":"11","author":"Golla","year":"2024","journal-title":"Front Mol Biosci"},{"issue":"6","key":"10.1016\/j.gendis.2025.101990_bib2","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/cancers13061372","article-title":"Non-coding RNAs in cancer diagnosis and therapy: focus on lung cancer","volume":"13","author":"Le","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"5","key":"10.1016\/j.gendis.2025.101990_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.gendis.2025.101990_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713617","article-title":"Various lncRNA mechanisms in gene regulation involving miRNAs or RNA-binding proteins in non-small-cell lung cancer: main signaling pathways and networks","volume":"24","author":"Braga","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10.1016\/j.gendis.2025.101990_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216213","article-title":"Non-coding RNAs in human cancer and other diseases: overview of the diagnostic potential","volume":"24","author":"Be\u0148a\u010dka","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.gendis.2025.101990_bib7","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.3390\/cancers12123657","article-title":"Non-coding RNAs as mediators of epigenetic changes in malignancies","volume":"12","author":"Kumar","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-020-01171-z","article-title":"Role of non-coding RNAs and RNA modifiers in cancer therapy resistance","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.gendis.2025.101990_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1374843","article-title":"Regulatory role of RNA-binding proteins in microRNA biogenesis","volume":"11","author":"Hynes","year":"2024","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.gendis.2025.101990_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/bs.mie.2023.02.023","article-title":"The pre-miRNA cleavage assays for DICER","volume":"692","author":"Le","year":"2023","journal-title":"Methods Enzymol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101990_bib11","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","article-title":"The miRNA-target interactions: an underestimated intricacy","volume":"52","author":"Diener","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.gendis.2025.101990_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101990_bib13","first-page":"54","article-title":"Understanding long noncoding RNA and chromatin interactions: what we know so far","volume":"5","author":"Mishra","year":"2019","journal-title":"Noncoding RNA"},{"issue":"3","key":"10.1016\/j.gendis.2025.101990_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","article-title":"The biogenesis, functions, and challenges of circular RNAs","volume":"71","author":"Li","year":"2018","journal-title":"Mol Cell"},{"issue":"10","key":"10.1016\/j.gendis.2025.101990_bib15","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3390\/jcm11102909","article-title":"Circular RNAs acting as miRNAs' sponges and their roles in stem cells","volume":"11","author":"Xiao","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.gendis.2025.101990_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114672","article-title":"Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research","volume":"162","author":"Ma","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gendis.2025.101990_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101730","article-title":"Unlocking the potential of non-coding RNAs in cancer research and therapy","volume":"35","author":"Uppaluri","year":"2023","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-022-00411-4","article-title":"Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis","volume":"56","author":"Zangouei","year":"2023","journal-title":"Biol Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101990_bib19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/ijms26030936","article-title":"Role of hypoxia-associated long noncoding RNAs in cancer chemo-therapy resistance","volume":"26","author":"Elahi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2025.101990_bib20","doi-asserted-by":"crossref","first-page":"1525373","DOI":"10.3389\/fendo.2025.1525373","article-title":"Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference","volume":"16","author":"Golounina","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.gendis.2025.101990_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1286","article-title":"Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy","volume":"10","author":"Afolabi","year":"2021","journal-title":"Clin Transl Immunology"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102440","article-title":"Nucleic acid therapeutics: past, present, and future","volume":"36","author":"Naeem","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12935-024-03549-1","article-title":"Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer","volume":"24","author":"Ge","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s40364-024-00701-x","article-title":"State of the art CRISPR-based strategies for cancer diagnostics and treatment","volume":"12","author":"Di Carlo","year":"2024","journal-title":"Biomark Res"},{"key":"10.1016\/j.gendis.2025.101990_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2023.09.029","article-title":"Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: a narrative review","volume":"363","author":"Doustmihan","year":"2023","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-023-02741-x","article-title":"Involvement of lncRNAs in cancer cells migration, invasion and metastasis: Cytoskeleton and ECM crosstalk","volume":"42","author":"Ahmad","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","article-title":"Long non-coding RNAs regulate drug resistance in cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101990_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27207","article-title":"Long non-coding RNAs in drug resistance across the top five cancers: update on their roles and mechanisms","volume":"10","author":"Shi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.gendis.2025.101990_bib30","doi-asserted-by":"crossref","first-page":"612393","DOI":"10.3389\/fmed.2020.612393","article-title":"Long non-coding RNAs in cancer: implications for diagnosis, prognosis, and therapy","volume":"7","author":"Qian","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.gendis.2025.101990_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-10-38","article-title":"The functional role of long non-coding RNA in human carcinomas","volume":"10","author":"Gibb","year":"2011","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/cancers16010234","article-title":"MALAT-1 is a key regulator of epithelial-mesenchymal transition in cancer: a potential therapeutic target for metastasis","volume":"16","author":"Ali Hussein","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.gendis.2025.101990_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.32607\/actanaturae.11905","article-title":"MALAT1 long non-coding RNA and its role in breast carcinogenesis","volume":"15","author":"Tsyganov","year":"2023","journal-title":"Acta Naturae"},{"key":"10.1016\/j.gendis.2025.101990_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112735","article-title":"The regulatory role of autophagy-related miRNAs in lung cancer drug resistance","volume":"148","author":"Shahverdi","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12935-024-03426-x","article-title":"The role of lncRNA NEAT1 in human cancer chemoresistance","volume":"24","author":"Long","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"23","key":"10.1016\/j.gendis.2025.101990_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312920","article-title":"HOXA11-As promotes lymph node metastasis through regulation of IFNL and HMGB family genes in pancreatic cancer","volume":"25","author":"Nishiyama","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2025.101990_bib37","first-page":"39","article-title":"Tumor suppressive effects of GAS5 in cancer cells","volume":"8","author":"Kaur","year":"2022","journal-title":"Noncoding RNA"},{"issue":"6","key":"10.1016\/j.gendis.2025.101990_bib38","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201389","article-title":"LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K\/AKT pathway via sponging miR-613","volume":"41","author":"Yao","year":"2021","journal-title":"Biosci Rep"},{"issue":"9","key":"10.1016\/j.gendis.2025.101990_bib39","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/cancers14092101","article-title":"The mechanisms of lncRNA-mediated multidrug resistance and the clinical application prospects of lncRNAs in breast cancer","volume":"14","author":"Ye","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.gendis.2025.101990_bib40","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.3390\/ijms21114012","article-title":"Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2025.101990_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.964934","article-title":"The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer","volume":"12","author":"Yong","year":"2022","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.gendis.2025.101990_bib42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4251\/wjgo.v11.i11.957","article-title":"Non-coding RNA in drug resistance of gastric cancer","volume":"11","author":"Luo","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.gendis.2025.101990_bib43","article-title":"Long non-coding RNA in gastric cancer: mechanisms and clinical implications for drug resistance","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"17","key":"10.1016\/j.gendis.2025.101990_bib44","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2025.101990_bib45","series-title":"Luminal A Breast Cancer Resistance Mechanisms and Emerging Treatments. Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance","first-page":"1","author":"Anderson","year":"2021"},{"issue":"5","key":"10.1016\/j.gendis.2025.101990_bib46","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/cancers12051197","article-title":"Long non-coding RNA HOTAIR in breast cancer therapy","volume":"12","author":"Cantile","year":"2020","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.gendis.2025.101990_bib47","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/cancers14215206","article-title":"Molecular mechanisms of anti-estrogen therapy resistance and novel targeted therapies","volume":"14","author":"Ozyurt","year":"2022","journal-title":"Cancers"},{"issue":"Pt B","key":"10.1016\/j.gendis.2025.101990_bib48","article-title":"CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p\/AKT3\/mTOR axis in tamoxifen-resistant MCF7 cells","volume":"311","author":"Moradi","year":"2022","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12967-020-02240-z","article-title":"Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer","volume":"18","author":"Wu","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.gendis.2025.101990_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100851","article-title":"Long non-coding RNA mediated drug resistance in breast cancer","volume":"63","author":"Singh","year":"2022","journal-title":"Drug Resist Updat"},{"issue":"9","key":"10.1016\/j.gendis.2025.101990_bib51","first-page":"2993","article-title":"Recent progress in treatment of hepatocellular carcinoma","volume":"10","author":"Chen","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"9","key":"10.1016\/j.gendis.2025.101990_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/microorganisms7090277","article-title":"Infections due to multidrug-resistant bacteria in oncological patients: insights from a five-year epidemiological and clinical analysis","volume":"7","author":"Perdikouri","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cancers14010048","article-title":"Cell death in hepatocellular carcinoma: pathogenesis and therapeutic opportunities","volume":"14","author":"Garc\u00eda-Pras","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.gendis.2025.101990_bib54","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/jpm12101605","article-title":"Radio-lncRNAs: biological function and potential use as biomarkers for personalized oncology","volume":"12","author":"Koz\u0142owska-Mas\u0142o\u0144","year":"2022","journal-title":"J Pers Med"},{"issue":"45","key":"10.1016\/j.gendis.2025.101990_bib55","doi-asserted-by":"crossref","first-page":"30880","DOI":"10.1074\/jbc.R114.609248","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1), a \u201cmultitasking\u201d ATP-binding cassette (ABC) transporter","volume":"289","author":"Cole","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gendis.2025.101990_bib56","article-title":"Immune evasion and drug resistance mediated by USP22 in cancer: novel targets and mechanisms","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2025.101990_bib57","article-title":"The emerging roles of circular RNAs in the chemoresistance of gastrointestinal cancer","volume":"10","author":"Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101990_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/14737140.2016.1170596","article-title":"Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles","volume":"16","author":"Rossi","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41420-022-01174-3","article-title":"Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance","volume":"8","author":"Zhu","year":"2022","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib60","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1186\/s12885-022-10188-0","article-title":"LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21\/PTEN axis","volume":"22","author":"Du","year":"2022","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.gendis.2025.101990_bib61","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/ph14090871","article-title":"Crosstalk of the Wnt\/\u03b2-catenin signaling pathway in the induction of apoptosis on cancer cells","volume":"14","author":"Trejo-Solis","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.gendis.2025.101990_bib62","article-title":"Biological function of long non-coding RNA (lncRNA) xist","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.gendis.2025.101990_bib63","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.2147\/OTT.S261461","article-title":"Long non-coding RNA BLACAT1 in human cancers","volume":"13","author":"Ye","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.gendis.2025.101990_bib64","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/ijms22041931","article-title":"The role of IGF\/IGF-1R signaling in hepatocellular carcinomas: Stemness-related properties and drug resistance","volume":"22","author":"Ngo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gendis.2025.101990_bib65","article-title":"The mechanism of long non-coding RNA in cancer radioresistance\/radiosensitivity: a systematic review","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41419-020-03318-8","article-title":"LncRNA DANCR represses doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells","volume":"12","author":"Xiong","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41420-022-00886-w","article-title":"Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1\/miR-140-3p\/ATG5 axis","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3892\/ijmm.2024.5456","article-title":"Interplay between lncRNAs and the PI3K\/AKT signaling pathway in the progression of digestive system neoplasms (Review)","volume":"55","author":"Zhang","year":"2025","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41420-024-01892-w","article-title":"NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence","volume":"10","author":"Zhen","year":"2024","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib70","first-page":"vdac119","article-title":"Modulating glioblastoma chemotherapy response: evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes","volume":"4","author":"Yuan","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib71","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma","volume":"22","author":"An","year":"2023","journal-title":"Mol Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2025.101990_bib72","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41419-020-2735-2","article-title":"Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer","volume":"11","author":"Fang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2025.101990_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200238","article-title":"Cervical cancer therapies: current challenges and future perspectives","volume":"13","author":"Burmeister","year":"2022","journal-title":"Tumour Virus Res"},{"issue":"8","key":"10.1016\/j.gendis.2025.101990_bib74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/cas.12461","article-title":"Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR\u2013STAT3\/microRNA143 pathway","volume":"105","author":"Li","year":"2014","journal-title":"Cancer Sci"},{"issue":"12","key":"10.1016\/j.gendis.2025.101990_bib75","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.3390\/curroncol29120779","article-title":"Zinc finger proteins in head and neck squamous cell carcinomas: ZNF540 may serve as a biomarker","volume":"29","author":"Soboci\u0144ska","year":"2022","journal-title":"Curr Oncol"},{"issue":"19","key":"10.1016\/j.gendis.2025.101990_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910689","article-title":"Wee1 kinase: a potential target to overcome tumor resistance to therapy","volume":"22","author":"Esposito","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12885-023-11743-z","article-title":"The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers","volume":"24","author":"Ghasemian","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gendis.2025.101990_bib78","doi-asserted-by":"crossref","first-page":"8365","DOI":"10.2147\/IJGM.S393270","article-title":"Upregulation of long noncoding RNA MALAT1 in colorectal cancer promotes radioresistance and aggressive malignance","volume":"15","author":"Shen","year":"2022","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12935-020-01740-8","article-title":"CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma","volume":"21","author":"Xu","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.gendis.2025.101990_bib80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3892\/ijo.2024.5610","article-title":"Advances in the study of antisense long-stranded non-coding RNAs in tumors (Review)","volume":"64","author":"Shao","year":"2024","journal-title":"Int J Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101990_bib81","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.7150\/jca.37242","article-title":"Inhibiting EMT, stemness and cell cycle involved in baicalin-induced growth inhibition and apoptosis in colorectal cancer cells","volume":"11","author":"Yang","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.gendis.2025.101990_bib82","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8352579","article-title":"Long noncoding RNA NEAT1 regulates TGF-\u03b22-induced epithelial-mesenchymal transition of lens epithelial cells through the miR-34a\/Snail1 and miR-204\/Zeb1 pathways","volume":"2020","author":"Dong","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.gendis.2025.101990_bib83","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.omtn.2021.04.002","article-title":"The role of m6A modification in the regulation of tumor-related lncRNAs","volume":"24","author":"Lan","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"10.1016\/j.gendis.2025.101990_bib84","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.7150\/ijbs.70292","article-title":"Emerging roles of lncRNA in nasopharyngeal carcinoma and therapeutic opportunities","volume":"18","author":"Wang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.gendis.2025.101990_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4279039","article-title":"ceRNAs in cancer: mechanism and functions in a comprehensive regulatory network","volume":"2021","author":"Yang","year":"2021","journal-title":"J Oncol"},{"key":"10.1016\/j.gendis.2025.101990_bib86","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221085373","article-title":"Four m6A RNA methylation gene signatures and their prognostic values in lung adenocarcinoma","volume":"21","author":"Wang","year":"2022","journal-title":"Technol Cancer Res Treat"},{"issue":"51","key":"10.1016\/j.gendis.2025.101990_bib87","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032399","article-title":"Prognostic and therapeutic implication of m6A methylation in Crohn disease","volume":"101","author":"He","year":"2022","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.gendis.2025.101990_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300528","article-title":"Nanomaterials-based targeting of long non-coding RNAs in cancer: a cutting-edge review of current trends","volume":"19","author":"Davodabadi","year":"2024","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s43042-025-00689-5","article-title":"The role of non-coding RNAs (ncRNAs) and their potential connection with cancer","volume":"26","author":"Absalan","year":"2025","journal-title":"Egypt J Med Hum Genet"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib90","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","article-title":"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.gendis.2025.101990_bib91","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3390\/ijms26073055","article-title":"The application of non-coding RNAs as biomarkers, therapies, and novel vaccines in diseases","volume":"26","author":"Yang","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"33","key":"10.1016\/j.gendis.2025.101990_bib92","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030045","article-title":"Role of noncoding RNAs and untranslated regions in cancer: a review","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188491","article-title":"Non-coding RNAs and potential therapeutic targeting in cancer","volume":"1875","author":"Toden","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.gendis.2025.101990_bib94","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1016\/j.csbj.2021.10.009","article-title":"AI applications in functional genomics","volume":"19","author":"Caudai","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"10.1016\/j.gendis.2025.101990_bib95","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target Oncol"},{"key":"10.1016\/j.gendis.2025.101990_bib96","article-title":"Non-coding RNA in cancer drug resistance: underlying mechanisms and clinical applications","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.gendis.2025.101990_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110572","article-title":"Strategies and technologies for exploring long noncoding RNAs in heart failure","volume":"131","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gendis.2025.101990_bib98","doi-asserted-by":"crossref","first-page":"543","DOI":"10.18632\/oncotarget.28447","article-title":"Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment","volume":"14","author":"Feichtenschlager","year":"2023","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.gendis.2025.101990_bib99","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ncrna.2023.10.002","article-title":"Methods of miRNA delivery and possibilities of their application in neuro-oncology","volume":"8","author":"Gareev","year":"2023","journal-title":"Noncoding RNA Res"},{"issue":"7","key":"10.1016\/j.gendis.2025.101990_bib100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/ph16070970","article-title":"Advances with lipid-based nanosystems for siRNA delivery to breast cancers","volume":"16","author":"Subhan","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.gendis.2025.101990_bib101","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"10.1016\/j.gendis.2025.101990_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111596","article-title":"ncRNAs in therapeutics: challenges and limitations in nucleic acid-based drug delivery","volume":"22","author":"Hueso","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2025.101990_bib103","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of microRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.gendis.2025.101990_bib104","first-page":"70","article-title":"An overview of the immune modulatory properties of long non-coding RNAs and their potential use as therapeutic targets in cancer","volume":"9","author":"Martinez-Castillo","year":"2023","journal-title":"Noncoding RNA"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:43:00Z","timestamp":1790012580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225004799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2352304225004799"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101990","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic resistance in cancer: lncRNAs as modulators and targets for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101990"}}